Premium
High expression of ovarian cancer immunoreactive antigen domain containing 2 (OCIAD2) is associated with poor prognosis in lung adenocarcinoma
Author(s) -
Sakashita Mai,
Sakashita Shingo,
Murata Yoshihiko,
ShibaIshii Aya,
Kim Yunjung,
Matsuoka Ryota,
Nakano Noriyuki,
Sato Yukio,
Noguchi Masayuki
Publication year - 2018
Publication title -
pathology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 74
eISSN - 1440-1827
pISSN - 1320-5463
DOI - 10.1111/pin.12724
Subject(s) - adenocarcinoma , immunohistochemistry , pathology , lung , lung cancer , pathological , stage (stratigraphy) , medicine , lymphovascular invasion , biomarker , cancer , biology , metastasis , paleontology , biochemistry
The clinicopathological implications of ovarian cancer immunoreactive antigen domain containing 2 (OCIAD2) in lung adenocarcinoma were investigated. The expression of OCIAD2 in 191 surgically resected lung adenocarcinomas was examined using immunohistochemistry. OCIAD2 expression was quantified using the H‐score and dichotomized as high or low. High OCIAD2 protein expression was significantly correlated with vascular invasion ( P = 0.0018), lymphatic permeation ( P = 0.049), T factor ( P = 0.0024), and pathological stage ( P = 0.0003). High OCIAD2 expression was significantly associated with poorer overall survival (OS) ( n = 191, P = 0.0325). In peripheral‐type lung adenocarcinomas ( n = 161), high OCIAD2 expression was significantly associated with both poorer OS ( P = 0.0214) and poorer disease‐free survival ( P = 0.0496). Adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA) showed weaker OCIAD2 expression than invasive adenocarcinoma. Among small adenocarcinomas measuring 2 cm or less in greatest dimension classified according to the Noguchi's classification ( n = 79), invasive adenocarcinomas showed significantly higher OCIAD2 expression than non‐invasive adenocarcinomas ( P = 0.0007). Interestingly, OCIAD2 was expressed heterogeneously even within a tumor, and its expression was higher in areas of invasion than in areas of in situ spread. Our results suggest that OCIAD2 could be a useful prognostic biomarker of lung adenocarcinoma.